Estados Unidos

Dr. Felicia Cosman is Professor of Medicine at Columbia University and North American Co-Editor in Chief of Osteoporosis International. She has been involved in the clinical investigation of many pharmaceutical agents for osteoporosis, but the main focus of her research has been studying the use of anabolic medications, including teriparatide, abaloparatide and romosozumab. Dr. Cosman is a leader in concepts regarding early use of anabolic agents in high-risk patients, optimal treatment sequences, longterm treatment strategies and therapeutic goals for osteoporosis management.